Revumenib, Azacitidine, and VENetoclax in Newly Diagnosed KMT2A-Rearranged AML
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Azacitidine
Related studies linked through entity extraction aliases.
A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2/PHASE3
Ruxolitinib With Azacitidine Maintenance for the Treatment of Patients With Acute Myeloid Leukemia Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Azacitidine + Venetoclax VS Azacitidineas Maintenance Therapy in AML
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Phase1b/2 Trial Of AZA + APG1252 In Patients With High-Risk AML
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Venetoclax, Azacitidine and Liposomal Mitoxantrone for Newly Diagnosed AML
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Aclarubicin Plus With Azacitidine and Venetoclax in the Treatment of Acute Myeloid Leukemia
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Venetoclax, Azacitidine, and Mitoxantrone Hydrochloride Liposome Versus Idarubicin and Cytarabine in Newly Diagnosed AML
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Azacytidine, Venetoclax Plus Minus Quizartinib for First Line Older/Unfit AML Patients (VENP-A-QUI)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
VAH vs VA in Newly Diagnosed Elderly AML
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Effectiveness and Safety of ONUREG (Oral Azacitidine) in Chinese Patients With Acute Myeloid Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Assessing PI3K Gamma Inhibition With Azacitidine, Venetoclax and Eganelisib in Patients With Acute Myeloid Leukemia
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
A Study of the Combination of Ivosidenib, Azacitidine, and Venetoclax Followed by Ivosidenib Alone in People With Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- PHASE2
Azacitidine and Abatacept in Relapsed or Refractory T-Cell Lymphoma
- Status
- SUSPENDED
- Phase
- PHASE1
Pacritinib With Aza for Upfront Myelodysplastic Syndrome
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Imetelstat Combinations in Relapsed AML
- Status
- RECRUITING
- Phase
- PHASE1
Olutasidenib With Azacitidine Followed by Olutasidenib Maintenance for the Treatment of IDH1-mutated Acute Myeloid Leukemia in Patients With Prior Treatment With Venetoclax Plus a Hypomethylating Agent
- Status
- RECRUITING
- Phase
- PHASE2
Ascorbate in Myelodysplastic Syndrome
- Status
- RECRUITING
- Phase
- PHASE2
A Study of BL-M11D1 in Combination With Cytarabine + Daunorubicin or Venetoclax + Azacitidine in Patients With Acute Myeloid Leukemia
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2/PHASE3
High-dose Ascorbate (HDA) in Combination With Standard of Care Azacitidine and Venetoclax in Acute Myeloid Leukemia (AML)
- Status
- RECRUITING
- Phase
- PHASE1